Janux Therapeutics, Inc.
NASDAQ:JANX
23.98 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 430.605 | 19.205 | 51.426 | 35.582 | 7.813 | 0.658 |
| Short Term Investments
| 594.568 | 324.823 | 275.59 | 339.383 | 0 | 0 |
| Cash and Short Term Investments
| 1,025.173 | 344.028 | 327.016 | 374.965 | 7.813 | 0.658 |
| Net Receivables
| 5.381 | 2.161 | 0.7 | 0.2 | 8 | 0 |
| Inventory
| 0 | 0 | -0.7 | -0.2 | 0 | 0 |
| Other Current Assets
| 3.112 | 3.052 | 5.423 | 2.054 | 0.249 | 0 |
| Total Current Assets
| 1,033.666 | 349.241 | 332.439 | 377.019 | 16.062 | 0.658 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 24.15 | 27.841 | 29.365 | 1.597 | 0.155 | 0.021 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.816 | 0.816 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.7 | 3.325 | 1.39 | 0.392 | 0 | 0 |
| Total Non-Current Assets
| 27.85 | 31.166 | 31.571 | 2.805 | 0.155 | 0.021 |
| Total Assets
| 1,061.516 | 380.407 | 364.01 | 379.824 | 16.217 | 0.679 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.026 | 2.424 | 2.159 | 2.458 | 0.428 | 0.267 |
| Short Term Debt
| 3.498 | 1.517 | 0.763 | 0.388 | 0 | 4 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 1.705 | 5.406 | 5.163 | 1.95 | 0 |
| Other Current Liabilities
| 9.935 | 7.387 | 8.179 | 4.788 | 0.803 | 0.36 |
| Total Current Liabilities
| 17.459 | 13.033 | 16.507 | 12.797 | 3.181 | 4.627 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 21.276 | 23.025 | 24.542 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 2.221 | 0.7 | 6.05 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 21.624 | 0 |
| Total Non-Current Liabilities
| 21.276 | 23.025 | 26.763 | 0.7 | 27.674 | 3.996 |
| Total Liabilities
| 38.735 | 36.058 | 43.27 | 13.497 | 30.855 | 8.623 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 379.824 | 21.624 | 3.996 |
| Common Stock
| 0.059 | 0.046 | 0.042 | 0.041 | 0.001 | 0.001 |
| Retained Earnings
| -237.757 | -168.763 | -110.47 | -47.411 | -14.739 | -7.955 |
| Accumulated Other Comprehensive Income/Loss
| 2.163 | 0.665 | -1.535 | -0.27 | 0 | -3.996 |
| Other Total Stockholders Equity
| 1,258.316 | 512.401 | 432.703 | 413.967 | 0.1 | 0.01 |
| Total Shareholders Equity
| 1,022.781 | 344.349 | 320.74 | 366.327 | 6.986 | -7.944 |
| Total Equity
| 1,022.781 | 344.349 | 320.74 | 366.327 | -14.638 | -7.944 |
| Total Liabilities & Shareholders Equity
| 1,061.516 | 380.407 | 364.01 | 379.824 | 16.217 | 0.679 |